This Article Full Text Full Text (PDF) All Versions of this Article: 36/11/2457    most recent 01.STR.0000185672.10390.30v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sasaki, T. Articles by Morimoto, C. Search for Related Content PubMed PubMed Citation Articles by Sasaki, T. Articles by Morimoto, C. Related Collections Animal models of human disease Brain Circulation and Metabolism Genetics of Stroke

(Stroke. 2005;36:2457.)
© 2005 American Heart Association, Inc.

Original Contributions

Nedd9 Protein, a Cas-L Homologue, Is Upregulated After Transient Global Ischemia in Rats

Possible Involvement of Nedd9 in the Differentiation of Neurons After Ischemia

Takahiro Sasaki, MD, PhD; Satoshi Iwata, MD, PhD; Hirotaka James Okano, MD, PhD; Yasuyo Urasaki, MS; Junichi Hamada, MD, PhD; Hirotoshi Tanaka, MD, PhD; Nam H. Dang, MD, PhD; Hideyuki Okano, MD, PhD Chikao Morimoto, MD, PhD

From the Division of Clinical Immunology (T.S., S.I., Y.U., H.T., C.M.), Advanced Clinical Research Center, Institute of Medical Science, the University of Tokyo, Tokyo, Japan; the Departments of Physiology (H.J.O., H.O.) and Neurology (T.S., J.H.), Keio University School of Medicine; Core Research for Evolutional Science and Technology (H.J.O., H.O.), Japan Science and Technology Agency, Saitama, Japan; and the Department of Lymphoma/Myeloma (N.H.D.), MD Anderson Cancer Center, University of Texas, TX.

Correspondence to Chikao Morimoto, MD, PhD, Division of Clinical Immunology, Advanced Clinical Research Center, the Institute of Medical Science, the University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. E-mail morimoto{at}ims.u-tokyo.ac.jp

Background and Purpose— Some proteins involved in self-repair after stroke in the adult brain are primarily expressed during embryonic development and strongly down-regulated during the early postnatal phase. Neuronal precursor cell-expressed, developmentally down-regulated gene (Nedd) 9 was recognized to be identical to Crk-associated substrate lymphocyte type (Cas-L), a docking protein that associates with a variety of signaling molecules, such as focal adhesion kinase (FAK), proline-rich tyrosine kinase 2 (Pyk2), and Crk. We investigated the involvement of these proteins in the pathophysiology of global cerebral ischemia.

Methods— The mouse Cas-L/Nedd9 cDNAs were cloned. The expression and function of Cas-L/Nedd9 protein in the pathogenesis of global ischemia in rats was investigated by RT-PCR, Western blot analysis, and immunohistochemistry. The neurite outgrowth of the transfectants of Nedd9 deletion mutants in PC-12 cells was also assessed to clarify the function of the Nedd9 protein.

Results— Nedd9 was a splicing variant of Cas-L and was selectively induced in neurons of the cerebral cortex and hippocampus 1 to 14 days after the ischemia. Induced Nedd9 protein was tyrosine phosphorylated and was bound to FAK in dendrite and soma of neurons after the ischemia. Finally, it was demonstrated that Nedd9 promoted neurite outgrowth of PC-12 cells.

Conclusions— Our study may support the potential of Nedd9 for participation in the differentiation of neurons after global ischemia in rats.

Key Words: cerebral ischemia • global • rats • neural differentiation

This article has been cited by other articles:

				J. Chapuis, F. Moisan, G. Mellick, A. Elbaz, P. Silburn, F. Pasquier, D. Hannequin, C. Lendon, D. Campion, P. Amouyel, et al. Association study of the NEDD9 gene with the risk of developing Alzheimer's and Parkinson's disease Hum. Mol. Genet., September 15, 2008; 17(18): 2863 - 2867. [Abstract] [Full Text] [PDF]

				T. Marumo, K. Hishikawa, M. Yoshikawa, and T. Fujita Epigenetic Regulation of BMP7 in the Regenerative Response to Ischemia J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1311 - 1320. [Abstract] [Full Text] [PDF]

				Y. Li, A. Grupe, C. Rowland, P. Holmans, R. Segurado, R. Abraham, L. Jones, J. Catanese, D. Ross, K. Mayo, et al. Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease Hum. Mol. Genet., March 1, 2008; 17(5): 759 - 767. [Abstract] [Full Text] [PDF]

				G. M. O'Neill, S. Seo, I. G. Serebriiskii, S. R. Lessin, and E. A. Golemis A New Central Scaffold for Metastasis: Parsing HEF1/Cas-L/NEDD9 Cancer Res., October 1, 2007; 67(19): 8975 - 8979. [Abstract] [Full Text] [PDF]